参考文献/References:
[1] Weng J,Zhou Z,Guo L,et al.Incidence of type 1 diabetes in China, 2010-13:population based study[J].BMJ,2018,360:j5295.DOI:10.1136/bmj.j5295.
[2] Liu C,Yuan YC,Guo MN,et al.Incidence of type 1 diabetes may be underestimated in the Chinese population:evidence from 21.7 million people between 2007 and 2017[J].Diabetes Care,2021,44(11):2503-2509.DOI:10.2337/dc21-0342.
[3] Martyn-Nemeth P,Quinn L,Penckofer S,et al.Fear of hypoglycemia:influence on glycemic variability and self-management behavior in young adults with type 1 diabetes[J].J Diabetes Complications,2017,31(4):735-741.DOI:10.1016/j.jdiacomp.2016.12.015.
[4] Kietsiriroje N,Pearson S,Campbell M,et al.Double diabetes:a distinct high-risk group?[J].Diabetes Obes Metab,2019,21(12):2609-2618.DOI:10.1111/dom.13848.
[5] Cree-Green M,Stuppy JJ,Thurston J,et al.Youth with type 1 diabetes have adipose, hepatic,and peripheral insulin resistance[J].J Clin Endocrinol Metab,2018,103(10):3647-3657.DOI:10.1210/jc.2018-00433.
[6] Perseghin G,Lattuada G,De cobelli F,et al.Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes[J].Diabetologia,2005,48(12):2615-2621.DOI:10.1007/s00125-005-0014-5.
[7] Gregory JM,Cherrington AD,Moore DJ.The Peripheral Peril:injected insulin induces insulin insensitivity in type 1 diabetes[J].Diabetes,2020,69(5): 837-847.DOI:10.2337/dbi19-0026.
[8] Chan CL,Pyle L,Morehead R,et al.The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes[J].Pediatr Diabetes,2017,18(6):470-477.DOI:10.1111/pedi.12422.
[9] Williams KV,Erbey JR,Becker D,et al.Can clinical factors estimate insulin resistance in type 1 diabetes?[J].Diabetes,2000,49(4):626-632.DOI:10.2337/diabetes.49.4.626.
[10] Nyström T,Holzmann MJ,Eliasson B,et al.Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes[J].Diabetes Obes Metab,2018,20(3):556-563.DOI:10.1111/dom.13110.
[11] Ferreira-Hermosillo A,Ibarra-salce R,Rodríguez-malacara J,et al.Comparison of indirect markers of insulin resistance in adult patients with double diabetes[J].BMC Endocr Disord,2020,20(1):87.DOI:10.1186/s12902-020-00570-z.
[12] Zheng X,Huang B,Luo S,et al.A new model to estimate insulin resistance via clinical parameters in adults with type 1 diabetes[J].Diabetes Metab Res Rev,2017,33(4).DOI:10.1002/dmrr.2880.
[13] imoniene D,Platūkiene A,Prakapiene E,et al.Insulin resistance in type 1 diabetes mellitus and its association with patient's Micro-and macrovascular complications,sex Hormones,and other clinical data[J].Diabetes Ther,2020,11(1):161-174.DOI:10.1007/s13300-019-00729-5.
[14] Schauer IE,Snell-Bergeon JK,Bergman BC,et al.Insulin resistance,defective insulin-mediated fatty acid suppression,and coronary artery calcification in subjects with and without type 1 diabetes:the CACTI study[J].Diabetes,2011,60(1):306-314.DOI:10.2337/db10-0328.
[15] Helliwell R,Warnes H,Kietsiriroje N,et al.Body mass index,estimated glucose disposal rate and vascular complications in type 1 diabetes:beyond glycated haemoglobin[J].Diabet Med,2021,38(5):e14529.DOI:10.1111/dme.14529.
[16] Mao Y,Zhong W.Changes of insulin resistance status and development of complications in type 1 diabetes mellitus:analysis of DCCT/EDIC study[J].Diabetes Res Clin Pract,2022,184:109211.DOI:10.1016/j.diabres.2022.109211.
[17] Oza C,Khadilkar V,Karguppikar M,et al.Prevalence of metabolic syndrome and predictors of metabolic risk in Indian children,adolescents and youth with type 1 diabetes mellitus[J].Endocrine,2022,75(3):794-803.DOI:10.1007/s12020-021-02924-6.
[18] LAm-chung CE,Martínez Zavala N,Ibarra-salce R,et al.Association of estimated glucose disposal rate and chronic diabetic complications in patients with type 1 diabetes[J].Endocrinol Diabetes Metab,2021,4(4):e00288.DOI:10.1002/edm2.288.
[19] Wu N,Bredin SSD,Guan Y,et al.Cardiovascular health benefits of exercise training in persons living with type 1 diabetes: a Systematic review and meta-analysis[J].J Clin Med,2019,8(2).DOI:10.3390/jcm8020253.
[20] Rosenfalck AM,Almdal T,Viggers L,et al.A low-fat diet improves peripheral insulin sensitivity in patients with type 1 diabetes[J].Diabet Med,2006,23(4):384-392.DOI:10.1111/j.1464-5491.2005.01810.x.
[21] Liu YS,Chen CN,Chen ZG,et al.Vascular and metabolic effects of metformin added to insulin therapy in patients with type 1 diabetes:a systematic review and meta-analysis[J].Diabetes Metab Res Rev,2020,36(6):e3334.DOI:10.1002/dmrr.3334.
[22] Cree-Green M,Bergman BC,Cengiz E,et al.Metformin improves peripheral insulin sensitivity in youth with type 1 diabetes[J].J Clin Endocrinol Metab,2019,104(8):3265-3278.DOI:10.1210/jc.2019-00129.
[23] Dandona P,Mathieu C,Phillip M,et al.Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes(DEPICT-1):24 week results from a multicentre,double-blind,phase 3,randomised controlled trial[J].Lancet Diabetes Endocrinol,2017,5(11):864-876.DOI:10.1016/s2213-8587(17)30308-x.
[24] Mathieu C,Zinman B,Hemmingsson JU,et al.Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes:the ADJUNCT ONE treat-to-target randomized trial[J].Diabetes Care,2016,39(10):1702-1710.DOI:10.2337/dc16-0691.
[25] Avgerinos I,Manolopoulos A,Michailidis T,et al.Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes:a systematic review and network meta-analysis[J].Diabetes Obes Metab,2021,23(3):822-831.DOI:10.1111/dom.14291.
[26] Herrmann K,Brunell SC,Li Y,et al.Impact of disease duration on the effects of pramlintide in type 1 diabetes:a post hoc analysis of three clinical trials[J].Adv Ther,2016,33(5):848-861.DOI:10.1007/s12325-016-0326-5.
相似文献/References:
[1]刘丹丹,王丽,史兴晔,等.脂肪酸受体GPR120影响胰岛素受体底物-1的表达[J].国际内分泌代谢杂志,2014,(06):371.[doi:10.3760/cma.j.issn.1673-4157.2014.06.003]
Liu Dandan*,Wang Li,Shi Xingye,et al.Regulation of fatty acid receptor GPR120 on the expression of insulin receptor substrate-1[J].International Journal of Endocrinology and Metabolism,2014,(03):371.[doi:10.3760/cma.j.issn.1673-4157.2014.06.003]
[2]李新萍,张萍,李晓玉.螺内酯对特发性醛固酮增多症患者胰岛β细胞功能的影响[J].国际内分泌代谢杂志,2014,(06):379.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
Li Xinping,Zhang Ping,Li Xiaoyu..Effects of spironolactone on islet β cell function in patients with idiopathic hyperaldosteronism[J].International Journal of Endocrinology and Metabolism,2014,(03):379.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
[3]胡雅琴,包玉倩.维生素D对非酒精性脂肪性肝病的保护作用[J].国际内分泌代谢杂志,2014,(06):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
Hu Yaqin,Bao Yuqian..Protective effect of vitamin D on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(03):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
[4]张琳,王晓琳,李小英.雄激素与糖脂代谢的关系[J].国际内分泌代谢杂志,2014,(05):351.[doi:10.3760/cma.j.issn.1673-4157.2014.05.018]
Zhang Lin,Wang Xiaolin,Li Xiaoying..The relationship between testosterone and glycolipid,metabolism[J].International Journal of Endocrinology and Metabolism,2014,(03):351.[doi:10.3760/cma.j.issn.1673-4157.2014.05.018]
[5]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(03):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[6]王锐 陆强 王术艺 朱东林 蒋韬 马宁 刘悦 李燕莉
贾晓娇 姚立新.血清25羟维生素D及vaspin水平与妊娠糖尿病关系的研究[J].国际内分泌代谢杂志,2015,(05):306.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.005]
Wang Rui,Lu Qiang,Wang Shuyi,et al.Relationship between serum 25-hydroxyvitamin D, vaspin and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):306.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.005]
[7]黄祺 程海燕 卜瑞芳.1-磷酸鞘胺醇与胰岛素抵抗[J].国际内分泌代谢杂志,2015,(05):348.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.015]
Huang Qi,Cheng Haiyan,Bu Ruifang..Sphingosine-1-phosphate and insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(03):348.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.015]
[8]李少卿 王坚.2型糖尿病患者血25-羟维生素D3缺乏
对胰岛素抵抗及骨量的影响[J].国际内分泌代谢杂志,2015,(06):384.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.006]
Li Shaoqing*,Wang Jian..The influence of 25-hydroxyl vitamin D3 deficiency on insulin resistance and bone mass in patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):384.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.006]
[9]李晶,董荣娜,于德民.有氧运动对胰岛素抵抗小鼠visfatin
表达的影响[J].国际内分泌代谢杂志,2016,36(01):10.[doi:10.3760/cma.j.issn.1673-4157.2016.01.003]
Li Jing,Dong Rongna,Yu Demin..Effects of aerobic exercise on the expression of visfatin in mice with insulin resistance[J].International Journal of Endocrinology and Metabolism,2016,36(03):10.[doi:10.3760/cma.j.issn.1673-4157.2016.01.003]
[10]张琳,费雯婕,宋光耀.网膜素与代谢综合征[J].国际内分泌代谢杂志,2016,36(01):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
Zhang Lin*,Fei Wenjie,Song Guangyao..Omentin and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2016,36(03):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]